Antibody-drug conjugates and uses thereof

TW202641588APending Publication Date: 2026-10-16TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114150529
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-12-19
Filing Date
2025-12-22
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080782_001
    Figure TWG2TA001080782_001
  • Figure TWG2TA001080782_002
    Figure TWG2TA001080782_002
  • Figure TWG2TA001080782_003
    Figure TWG2TA001080782_003
Patent Text Reader

Abstract

The present disclosure relates to antibody-drug conjugates, and more particularly to antibody-drug conjugates (ADCs) loaded with Ras mutation inhibitors, compositions containing the ADC molecules and therapeutic uses thereof.
Need to check novelty before this filing date? Find Prior Art